Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Thermo Fisher Scientific serves conversion rights notice to debenture holders

Thermo Fisher Scientific serves conversion rights notice to debenture holders

8th July 2009

Thermo Fisher Scientific has provided public notice to the holders of floating rate convertible senior debentures due 2033 that they have the right to convert them under the terms of the indenture covering Apogent Technologies.

In a statement, the organisation said that the debentures are convertible due to the fact that Thermo Fisher Scientific stock traded higher than the minimum price specified in the terms of the indenture over the applicable measurement period.

"The debentures continue to be convertible until September 26th 2009 and may be convertible thereafter, depending on whether or not one of the conversion conditions specified in the indenture is satisfied during future measurement periods," it added.

Should conversion requests be received, Thermo Fisher Scientific, which recently named Tyler Jacks and Thomas Lynch to its board, reserves the right to decide if settlement will be paid in cash alone or a combination of money and shares of its own common stock.ADNFCR-1050-ID-19256136-ADNFCR

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.